Clinical value of combined detection of serum CA153, CA125, CA199 and CEA in breast cancer diagnosis
- Author:
- No author available
- Journal Title:
- Cancer Research and Clinic
- Issue:
- 8
- DOI:
- 10.3760/cma.j.issn.1006-9801.2012.08.016
- Key Word:
- 乳腺肿瘤;联合检测;肿瘤标志物;Breast neoplasms;Combined measurement;Tumor marker
Abstract： Objective To investigate the clinical value of combined measure of the serum levels of CA153,CA125,CA199 and CEA in the diagnosis of breast cancer.Methods Serum levels of CA153,CA125,CA199 and CEA in 68 patients with breast cancer,50 patients with benign breast diseases and 58 healthy volunteers were measured by electrochemiluminescence immunoassay (ECLIA).Results The levels of CA153,CA125,CA199 and CEA in breast cancer group were significantly higher than those in benign breast disease and healthy volunteers.Sensitivities of CA153,CA125,CA199 and CEA were 76.4 ％ (52/68),44.1％(30/68),35.3 ％ (24/68),29.4 ％ (20/68),respectively.The positive rate of combination of tumor markers was 94.1％ (64/68).Conclusion The combined assay of CA153,CA125,CA199 and CEA can improve the early diagnostic rate of breast cancer.
- [1]白树祥.癌胚抗原、糖类抗原15-3和细胞角蛋白片段19检测对乳腺癌临床应用的价值[J].2011,(2).
- [2]耿翠芝.与乳腺癌相关的肿瘤标志物研究现状及评价[J].2009,(1).
- [3]刘健.肿瘤标志物CEA,CA15-3对乳腺癌的疗效观察[J].2006,(4).
- [4]梁翠微,杨兵,李小亮,等.CA153、CA125、TSGF联合检测在乳腺癌中的临床意义[J].2004,(5).
- [5]李春海.加强肿瘤生物学标志的研究和评价[J].2000,(1).
- [6]陈运贤.恶性肿瘤的分子诊断技术[J].2009,(2).
- [7]吴健民.对肿瘤标志物的再认识[J].2005,(1).
- [8]Kemeny N,Locker GY,Fritsche H Jr,etc.2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.[J].2001,19(6).
- [9]Greenlee RT,Thun M,Hill-Harmon MB,etc.Cancer statistics, 2001.[J].2001,51(1).